• 尊龙凯时

    SynRx SynRx
    Using synthetic lethality strategy to target tumor cells with DNA damage repair defects
    Science Pipeline Technology
    Science
    SynRx
    SynRx
    SynRx
    Synthetic Lethality
    Synthetic lethality is derived from a genetic concept. In 1922, Calvin Bridge, a geneticist at Columbia University, was studying Drosophila melanogaster. He discovered that combinations of several mutations induced lethality, while flies were viable with any single gene mutation. Twenty-four years later, Theodore Dobzhansky, also working at Columbia University, used the term "synthetic lethal" to describe these genetic interactions. Till now, the definition of synthetic lethality is well beyond the classical genetic interactions, as it refers to cell death caused by simultaneous inhibition of two non-lethal genes.
    DNA Damage Repair
    In response to DNA damage, DNA damage repair (DDR) machinery senses and repairs DNA lesions. Since the lack of DDR leads to the accumulation of DNA lesions, which eventually causes genomic instability and tumorigenesis, many DDR factors play an important role in tumor suppressors. Hence, elucidating the mechanisms of DDR facilitates the development of novel cancer therapies.
    SynRx
    SynRx
    SynRx
    SynRx
    Potential cancer therapeutic targets
    SynRx
    Oncogene
    An oncogene is a gene that has the potential to cause cancer. In tumor cells, these genes are often mutated, or expressed at high levels.
    Targeted Therapy
    PARP inhibitors are the first examples of synthetic lethal targeting in a population of patients with mutations in the tumor suppressor gene BRCA.
    Tumor Suppressor Gene
    A tumor suppressor gene is a gene that regulates a cell during cell division and replication. When a tumor suppressor gene is mutated, it results in a loss or reduction in its function. In combination with other genetic mutations, this could allow the cell to grow abnormally.
    SynRx
    Business Development bd@mini818.com
    Careers hr@mini818.com
    Address @ Room 201, Building 4, 1390 Cangxing Street, Cangqian Subdistrict, Yuhang District, Hangzhou, Zhejiang @ Room 303, No.1, Lane 88, Shengrong Road, Zhangjiang High-Tech Park, Pudong New District, Shanghai
    CopyRight 2022 All Right Reserved SynRx Therapeutics 浙ICP备2021033925号 SiteMap
    SynRx
    SynRx
    SynRx
    0571-86360796
    SynRx